Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Capital Markets — Broking & AMC.”
₹402 Cr revenue.
COGS 0.0%, employees 47.0%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 18.7%▲ | 12.1% |
| ROCE | 24.5%▲ | 13.9% |
| Net Margin | 31.8%▲ | 26.4% |
| EBITDA Margin | 47.0%▲ | 43.4% |
| Debt To Equity | 0.00x▼ | 0.04x |
| Rev Growth 3yr | 18.1%▲ | 18.1% |
| EPS Growth 3yr | 21.9%▲ | 18.3% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹452 Cr +12.4% | ₹402 Cr +21.3% | ₹332 Cr +18.9% | ₹279 Cr +12.7% | ₹248 Cr -0.3% | ₹248 Cr +2.0% | ₹244 Cr -23.6% | ₹319 Cr |
| Other Income | ₹54 Cr +7.3% | ₹51 Cr +8.7% | ₹47 Cr +23.1% | ₹38 Cr +39.5% | ₹27 Cr -13.1% | ₹31 Cr -0.6% | ₹31 Cr +3.5% | ₹30 Cr |
| Total Income | ₹506 Cr +11.8% | ₹453 Cr +19.7% | ₹378 Cr +19.4% | ₹317 Cr +15.3% | ₹275 Cr -1.8% | ₹280 Cr +1.7% | ₹275 Cr -21.3% | ₹349 Cr |
| ₹284 Cr +9.0% | ₹261 Cr +12.5% | ₹232 Cr +21.2% | ₹191 Cr +8.5% | ₹176 Cr +9.4% | ₹161 Cr -5.8% | ₹171 Cr +15.8% | ₹148 Cr | |
| Profit Before Tax | ₹222 Cr +15.6% | ₹192 Cr +31.1% | ₹147 Cr +16.6% | ₹126 Cr +27.5% | ₹99 Cr -16.9% | ₹119 Cr +14.0% | ₹104 Cr -48.4% | ₹202 Cr |
| ₹59 Cr +12.1% | ₹52 Cr +18.6% | ₹44 Cr +9.4% | ₹40 Cr +84.8% | ₹22 Cr -21.2% | ₹28 Cr +34.3% | ₹21 Cr -67.6% | ₹64 Cr | |
| Net Profit | ₹164 Cr +16.9% | ₹140 Cr +36.5% | ₹103 Cr +20.0% | ₹85 Cr +11.2% | ₹77 Cr -15.5% | ₹91 Cr +9.0% | ₹83 Cr -39.5% | ₹138 Cr |
| Profit (Owners) | ₹161 Cr +17.3% | ₹137 Cr +36.5% | ₹101 Cr +21.6% | ₹83 Cr +10.1% | ₹75 Cr -16.1% | ₹90 Cr +8.7% | ₹82 Cr -40.1% | ₹137 Cr |
| Minority Interest | ₹3 Cr -3.5% | ₹3 Cr +35.5% | ₹2 Cr +4.9% | ₹2 Cr +13.0% | ₹2 Cr +18.7% | ₹1 Cr +30.7% | ₹1 Cr +86.3% | ₹0.60 Cr |
| Other Comprehensive Income | ₹1 Cr ↑ Recovery | (₹0.26 Cr) -8.2% | (₹0.24 Cr) +71.5% | (₹0.85 Cr) ↓ Decline | ₹8 Cr +261.9% | ₹2 Cr ↑ Recovery | (₹0.86 Cr) +58.1% | (₹2 Cr) |
| EPS | ₹53.69 | ₹45.85 | ₹33.67 | ₹27.83 | ₹25.33 | ₹30.38 | ₹27.96 | ₹46.66 |
| Diluted Shares | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
CARE Ratings Limited has informed the Exchange about Copy of Newspaper Publication
CARE Ratings Limited has informed the Exchange about Schedule of meet
CARE Ratings Limited has informed the Exchange about Transcript of the Earnings Conference Call held on May 14, 2026
CARE Ratings Limited has informed the Exchange about Schedule of meet
CARE Ratings Limited has informed the Exchange about Copy of Newspaper Publication pertaining to Financial Results of the Company for the quarter and year ended March 31, 2026
CARE Ratings Limited has informed the Exchange regarding a press release dated May 04, 2026, titled "NSE-CareEdge Ratings commercially launches PaRRVA, a standard framework for investment performance ...
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
CARE Ratings Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
CARE Ratings Limited has informed the Exchange about Action(s) taken or orders passed
CARE Ratings Limited has informed the Exchange about Schedule of investor meet
CARE Ratings Limited has informed the Exchange about Schedule of Investor meet
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
CARE Ratings Limited has informed the Exchange about General Updates
CARE Ratings Limited has informed the Exchange regarding allotment of 1650 securities pursuant to ESOP/ESPS at its meeting held on March 06, 2026
CARE Ratings Limited has informed the Exchange about Schedule of meet